Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference12 articles.
1. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.;Finberg;J Mol Diagn,2007
2. Inhibition of mutated, activated BRAF in metastatic melanoma.;Flaherty;N Engl J Med,2010
3. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer.;Fukuoka;J Clin Oncol,2003
4. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.;Gazdar;Oncogene,2009
5. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC.;Linardou;Nat Rev Clin Oncol,2009
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non–Small Cell Lung Cancer Patients;Cancer Epidemiology Biomarkers & Prevention;2019-02-20
2. Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors;Medicine;2015-12
3. A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer;International Journal of Molecular Medicine;2014-05-28
4. EGFR Mutations in Lung Cancer: Different Frequencies for Different Folks;Journal of Thoracic Oncology;2014-02
5. Role of the Pulmonologist in Ordering Post-Procedure Molecular Markers in Non-Small-Cell Lung Cancer: Implications for Personalized Medicine;CLIN LUNG CANCER;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3